-
Uncategorized2 months ago
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
-
Uncategorized2 months ago
How a 20-year old asthma drug is boosting food allergy research
How a 20-year old asthma drug is boosting food allergy research
-
Uncategorized2 months ago
Can AI Agents Automate Scientific Discovery?
Nvidia CEO Jensen Huang asserts that agentic AI systems are driving innovation across industries. At his annual NVIDIA GTC keynote, Huang highlighted OpenClaw, the personal AI...
-
Uncategorized2 months agoSTAT+: Insilico Medicine CEO on how best to use AI in drug development
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
Uncategorized2 months ago
Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug program. But for Valneva CEO...
-
Uncategorized2 months agoSTAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’re officially in...
-
Uncategorized2 months ago
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
-
Uncategorized2 months agoPartnership set to make therapies ‘reach patients sooner’
A new partnership could accelerate clinical trials and bring therapies to patients sooner. Clinical research organisation ICON has partnered with Advarra to introduce a new ‘research-ready’ site network...
-
Uncategorized2 months ago
FDA delays decision on Orca Bio cell therapy after filing more manufacturing data
The FDA has postponed its deadline on whether to approve Orca Bio’s T cell therapy by three months to July 6. The agency was expected to...
-
Uncategorized2 months ago
FDA, after turbulent year, leaves drugmakers guessing on its direction
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator is as unpredictable as it’s ever been. Read More
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
